Bictegravir, emtricitabine, and tenofovir and Hepatic dysfunction
Result of checking the interaction of drug Bictegravir, emtricitabine, and tenofovir and disease Hepatic dysfunction for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:The use of bictegravir is not recommended in patients with severe hepatic impairment (Child-Pugh Class C). No dosage adjustment is recommended in patients with mild (Child-Pugh Class A) or moderate (Child-Pugh Class B) hepatic impairment.
Generic Name: bictegravir / emtricitabine / tenofovir alafenamide
Brand Name: Biktarvy
Synonyms: Bictegravir, Emtricitabine, and Tenofovir Alafenamide
Bictegravir, emtricitabine, and tenofovir - zaburzenia czynności wątroby 
Bictegravir, emtricitabine, and tenofovir - disfunção hepática 
Bictegravir, emtricitabine, and tenofovir - disfungsi hepatik 
Bictegravir, emtricitabine, and tenofovir - disfungsi hati 
Bictegravir, emtricitabine, and tenofovir - disfunzione epatica 
Bictegravir, emtricitabine, and tenofovir - dysfonctionnement hépatique 
Bictegravir, emtricitabine, and tenofovir - Leberfunktionsstörung 
Bictegravir, emtricitabine, and tenofovir - disfunción hepática 
Bictegravir, emtricitabine, and tenofovir - печеночная дисфункция 
Bictegravir, emtricitabine, and tenofovir - hepatik disfonksiyon 
Bictegravir, emtricitabine, and tenofovir - ضعف الكبد 
Bictegravir, emtricitabine, and tenofovir - 肝功能障碍